Compl'Alim is a state startup sponsored by the DGAL. In response to growing concerns about safety and transparency in this expanding sector, Compl'Alim aims to replace the current tool Teleicare by providing more modern and effective solutions.
In 2023, the French dietary supplements market generated a turnover of 2.7 billion, with a growth of 3% compared to the previous year. This sector is experiencing continuous growth, driven by increased demand for wellness and health products. Distribution channels are diversifying, with a strong presence in pharmacies, specialty stores, and increasingly on online platforms.
However, this rapid growth comes with challenges, particularly in terms of regulation and public safety. Consumers can be exposed to risks due to misuse or interactions with medications. The current regulatory framework also has gaps, being considered less rigorous than that applied to medicines. Unlike medicines, dietary supplements do not require Marketing Authorization (MA) to be sold, provided they contain authorized ingredients and quantities.
Compl'Alim aims to optimize the notification of dietary supplements in France. Its missions include facilitating the processing of dossiers, empowering industry professionals, and informing consumers. Compl'Alim is committed to making the declaration process more efficient and transparent.
To achieve its objectives, the startup has developed a new database, a powerful search engine, and an automated pathway for declaring dietary supplements. These tools allow for better traceability and easier access to information for all market players.
The main innovations include:
- A search engine dedicated to ingredients and substances.
- Automatic guidance towards the appropriate declaration procedure based on product composition.
Compl'Alim plans to replace Teleicare, the current tool for declaring dietary supplements, which has become outdated. The goal is to modernize, simplify, and make the process of dossier processing and control more efficient. Teleicare no longer meets current regulatory challenges, and Compl'Alim offers solutions to address this situation.
Thanks to Compl'Alim's efforts, the transparency and accessibility of data will be significantly improved. Industry professionals will have access to clear and detailed information, while consumers will benefit from greater safety and confidence in the products they use.
Compl'Alim has several future development phases planned. Among them are the creation of an open data catalog and the implementation of a system allowing consumers to report undeclared products. These initiatives aim to enhance transparency and collaboration within the industry.
Compl'Alim's vision is to become the primary tool for declaring dietary supplements by September 2024. To achieve this goal, key milestones in various development and online projects are planned from March 2024 to January 2025.
- Period: March to September 2024
- Users: Professionals, Administration, Data Reusers
- Period: March to September 2024
- Users: Professionals, Administration
- Period: September 2024 to January 2025
- Users: Professionals, Administration
- Period: September 2024 to January 2025
- Users: Professionals, Consumers
- Period: September 2024 to January 2025
- Users: Data Reusers, Consumers
Discover Compl'Alim's roadmap in this article: "Compl'Alim: Towards the Circulation of Dietary Supplements that Comply with Regulations, Are Safe for Public Health, and Adapted to Consumers' Physiological Needs."
In summary, Compl'Alim plays a crucial role in improving the notification procedure for dietary supplements in France. By implementing innovative technological tools and promoting transparency, this startup is committed to enhancing public safety and consumer confidence.
_
Compl'Alim is a state startup sponsored by the DGAL. In response to growing concerns about safety and transparency in this expanding sector, Compl'Alim aims to replace the current tool Teleicare by providing more modern and effective solutions.
In 2023, the French dietary supplements market generated a turnover of 2.7 billion, with a growth of 3% compared to the previous year. This sector is experiencing continuous growth, driven by increased demand for wellness and health products. Distribution channels are diversifying, with a strong presence in pharmacies, specialty stores, and increasingly on online platforms.
However, this rapid growth comes with challenges, particularly in terms of regulation and public safety. Consumers can be exposed to risks due to misuse or interactions with medications. The current regulatory framework also has gaps, being considered less rigorous than that applied to medicines. Unlike medicines, dietary supplements do not require Marketing Authorization (MA) to be sold, provided they contain authorized ingredients and quantities.
Compl'Alim aims to optimize the notification of dietary supplements in France. Its missions include facilitating the processing of dossiers, empowering industry professionals, and informing consumers. Compl'Alim is committed to making the declaration process more efficient and transparent.
To achieve its objectives, the startup has developed a new database, a powerful search engine, and an automated pathway for declaring dietary supplements. These tools allow for better traceability and easier access to information for all market players.
The main innovations include:
- A search engine dedicated to ingredients and substances.
- Automatic guidance towards the appropriate declaration procedure based on product composition.
Compl'Alim plans to replace Teleicare, the current tool for declaring dietary supplements, which has become outdated. The goal is to modernize, simplify, and make the process of dossier processing and control more efficient. Teleicare no longer meets current regulatory challenges, and Compl'Alim offers solutions to address this situation.
Thanks to Compl'Alim's efforts, the transparency and accessibility of data will be significantly improved. Industry professionals will have access to clear and detailed information, while consumers will benefit from greater safety and confidence in the products they use.
Compl'Alim has several future development phases planned. Among them are the creation of an open data catalog and the implementation of a system allowing consumers to report undeclared products. These initiatives aim to enhance transparency and collaboration within the industry.
Compl'Alim's vision is to become the primary tool for declaring dietary supplements by September 2024. To achieve this goal, key milestones in various development and online projects are planned from March 2024 to January 2025.
- Period: March to September 2024
- Users: Professionals, Administration, Data Reusers
- Period: March to September 2024
- Users: Professionals, Administration
- Period: September 2024 to January 2025
- Users: Professionals, Administration
- Period: September 2024 to January 2025
- Users: Professionals, Consumers
- Period: September 2024 to January 2025
- Users: Data Reusers, Consumers
Discover Compl'Alim's roadmap in this article: "Compl'Alim: Towards the Circulation of Dietary Supplements that Comply with Regulations, Are Safe for Public Health, and Adapted to Consumers' Physiological Needs."
In summary, Compl'Alim plays a crucial role in improving the notification procedure for dietary supplements in France. By implementing innovative technological tools and promoting transparency, this startup is committed to enhancing public safety and consumer confidence.
_